Novartis AG Finance Costs Paid Classified As Operating Activities
Novartis AG (NVSEF) reported Finance Costs Paid Classified As Operating Activities of $26.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:FinanceCostsPaidClassifiedAsOperatingActivities · last filed 2026-02-04
- Novartis AG finance costs paid classified as operating activities for the quarter ending 2024-06-30 was $65.00M, a 1525.00% increase year-over-year.
- Novartis AG finance costs paid classified as operating activities for the quarter ending 2023-06-30 was $4.00M, a 69.23% decline year-over-year.
- Novartis AG finance costs paid classified as operating activities for the quarter ending 2022-06-30 was $13.00M, a 66.67% decline year-over-year.
- Novartis AG finance costs paid classified as operating activities for the quarter ending 2021-06-30 was $39.00M, a 290.00% increase year-over-year.
| Period end | Finance Costs Paid Classified As Operating Activities 3 month | Finance Costs Paid Classified As Operating Activities 3 month as first filed | Finance Costs Paid Classified As Operating Activities 6 month | Finance Costs Paid Classified As Operating Activities 6 month as first filed | Finance Costs Paid Classified As Operating Activities 12 month | Finance Costs Paid Classified As Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $26.00M 20-F · filed 2026-02-04 | |||||
| 2024-12-31 | $116.00M 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $65.00M 6-K · filed 2024-07-18 | $94.00M 6-K · filed 2024-07-18 | ||||
| 2023-12-31 | $17.00M 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $4.00M 6-K · filed 2024-07-18 | $5.00M 6-K · filed 2023-07-18 | $10.00M 6-K · filed 2024-07-18 | $11.00M 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $26.00M 20-F · filed 2025-01-31 | $32.00M 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $13.00M 6-K · filed 2023-07-18 | $43.00M 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | $297.00M 20-F · filed 2024-01-31 | $302.00M 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $39.00M 6-K · filed 2022-07-19 | $322.00M 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $39.00M 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | $10.00M 6-K · filed 2021-07-21 | $19.00M 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | $33.00M 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | -$28.00M 6-K · filed 2020-07-21 | $16.00M 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $31.00M 20-F · filed 2021-01-26 | $32.00M 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | -$49.00M 6-K · filed 2019-07-18 | $14.00M 6-K · filed 2019-07-18 | $15.00M 6-K · filed 2018-07-18 | |||
| 2017-12-31 | $270.00M 20-F · filed 2020-01-29 | $272.00M 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | $22.00M 6-K · filed 2018-07-18 | $27.00M 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $155.00M 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $23.00M 6-K · filed 2018-01-24 |